Your review * Great product Easy to refill and fair pricing
doi:10.1021/acs.molpharmaceut.1c00689
As stated in the CY 2025 PFS proposed rule (89 FR 61982), based on these considerations, we believe that, to capture an accurate rebate amount and consistent with reconciliations of pricing data submitted to CMS that provide for revisions when necessary due to errors, including mathematical errors, and manufacturer misreporting, certain circumstances merit reconciliation of the rebate amount separate from the 12- and 36-month reconciliations proposed at 428.401(d)(1)
(5)Fmoc-Asp(otBu)-Ala-Gly-Leu-Val- (5) Preparation of Fmoc-Asp(otBu)-Ala-Gly-Leu-Val-resin: (4)Fmoc-Ala-Gly-Leu-Val-1050530105010603DMF3DMF2DMFFmoc-Asp(otBu)-OHDIEATBTU/HOBtHBTU/HOBtBOP/HOBt105010603DMF3DMF2Fmoc-Asp(otBu)-Ala-Gly-Leu-Val- In the Fmoc-Ala-Gly-Leu-Val-resin in step (4), add the decapping reagent at 10-50C and react for 5-30 minutes, dry it with a vacuum pump, and add the decapping reagent again at 10-50C for 10-60 minutes , drained, washed 3 times with isopropanol, 3 times with DMF, 2 times with re-distilled DMF, added Fmoc-Asp(otBu)-OH, DIEA, TBTU/HOBt or HBTU/HOBt dissolved in DMF or The mixture of BOP/HOBt was reacted at 10-50C for 10-60 minutes, dried by vacuum pump, washed 3 times with isopropanol, washed 3 times with DMF, washed 2 times with re-distilled DMF, and dried to obtain Fmoc-Asp (otBu)-Ala-Gly-Leu-Val-resin
Preventing Complications: Early treatment significantly lowers the risk of developing long-term complications like postherpetic neuralgia (PHN)
